These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6192269)

  • 1. [Tumor marker in urology].
    Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
    Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastasis and markers].
    Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
    Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of various markers (alpha fetoprotein, chorionic gonadotropin, lactate dehydrogenase) during chemotherapy of malignant testicular tumors].
    Lichinitser MR; Bassalyk LS; Levina DM; Pashintseva LP; Molodyk AA
    Ter Arkh; 1984; 56(6):77-9. PubMed ID: 6206585
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H; Kameyama S; Aso Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
    Dunzendorfer U; Jurincic C
    Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.